• Home
  • Sector News
    • Technology
    • Energy
    • Financial Services
  • Opinion and Analysis
    • Market Overview
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Investment Idea
    • Stock Market
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Stock Pick
  • Virtus Report

Subscribe to stay informed!

Discover hidden stock market gems and stay up to date with our weekly email newsletter and individual stock ideas

What's Hot

Your Investment Went Up 10,000%, Now What Should You Do, Sell or Let it Ride? – NVIDIA (NASDAQ:NVDA)

June 6, 2023

HCA Healthcare (HCA) Favors Higher In Bullish Sequence & Remain Supported

June 6, 2023

Cathie Wood Buys $21M Worth of Coinbase Shares Despite SEC Lawsuit

June 6, 2023
Telegram RSS
  • Government
  • Press Releases
  • Stock Market
  • Top Stories
  • Trading Insights
  • Trending
Telegram RSS
Virtus Junxit EquitiesVirtus Junxit Equities
  • Home
  • Sector News
    1. Technology
    2. Energy
    3. Financial Services
    4. View All

    Your Investment Went Up 10,000%, Now What Should You Do, Sell or Let it Ride? – NVIDIA (NASDAQ:NVDA)

    June 6, 2023

    Datalink Networks Taps Former Microsoft Senior Solutions Architect Aman Sahota as Director of Engineering

    June 6, 2023

    Musk: China is Focusing on AI Dominance and the US is Falling Behind in Regulation

    June 6, 2023

    ASTRALCOM Launches New Website for Rijke Consulting

    June 6, 2023

    Crude oil prices fall due to a strong dollar and weak economic news

    June 6, 2023

    Natural Gas Sees Small Increases Due to High Temperatures in the United States

    June 6, 2023

    Are the Bears Leading the Way?

    June 6, 2023

    Global Energy Demand Concerns Impacting Crude Oil Prices

    June 6, 2023

    HCA Healthcare (HCA) Favors Higher In Bullish Sequence & Remain Supported

    June 6, 2023

    Topeka, Kansas, Offers $15K Relocation Incentive for New Residents

    June 6, 2023

    Caring Transitions of Central Arizona awarded Chandler 2023 Micro Business of the Year

    June 6, 2023

    SPY ETF: More Buyers Enter in Wave ii Pullback

    June 6, 2023

    Your Investment Went Up 10,000%, Now What Should You Do, Sell or Let it Ride? – NVIDIA (NASDAQ:NVDA)

    June 6, 2023

    HCA Healthcare (HCA) Favors Higher In Bullish Sequence & Remain Supported

    June 6, 2023

    Cathie Wood Buys $21M Worth of Coinbase Shares Despite SEC Lawsuit

    June 6, 2023

    Paratek Pharmaceuticals to be Acquired by Gurnet Point and Novo Holdings for $462M – PRTK Stock

    June 6, 2023
  • Opinion and Analysis
    • Market Overview
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Investment Idea
    • Stock Market
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Stock Pick
  • Virtus Report
Get Access
Virtus Junxit EquitiesVirtus Junxit Equities
Home»Government»Evaluation of Health Canada’s THC Restrictions on Cannabis Markets, Packaging, and Potency
Government

Evaluation of Health Canada’s THC Restrictions on Cannabis Markets, Packaging, and Potency

JamesBy JamesMay 25, 2023Updated:May 25, 2023No Comments2 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

Health Canada has asked licensed cannabis companies to stop the sale of certain ingestible marijuana products characterized as “ingestible extracts” instead of edibles. Canadian edibles have a maximum THC limit of 10mg per package, whereas extracts or concentrates may have much higher THC levels in each package.

According to a report by data firm, Headset, Health Canada’s regulations on THC limits for edibles might have significant effects on the cannabis market, potency, and packaging. The report’s key findings include:

  • Though edibles are the fourth most popular category of product in Canada, they are not as popular as they are in America, partly due to the strict 10-milligram THC limit in Canada.
  • Some edible producers in Canada have sidestepped THC limitations by designating their products as “ingestible extracts,” a classification that allows them to exceed the 10 milligrams of THC per package limit.
  • Cannabis consumers in Canada prefer affordable and valuable packaging, and the market is dominated by high potency products, representing 17.7% of all edible sales between January to April 2023.
  • Headset’s researchers say that restricting high total package potency may harm the edible category, leading to decreased consumer spending and financial losses for producers.
  • The researchers conclude that restricting high total package potency in Canada could result in a negative impact on the edible category, lower consumer spending, and financial harm for producers.

Related News

Photo by Elsa Olofsson on Unsplash. 

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleDefault Mode
Next Article Ronald W. Jenssen Recognized for Achievements in Business
James

    Related Posts

    Understanding the Trading Activity of Congress with Microsoft Transactions

    June 6, 2023By James0

    Rep. Mark Green Sold up to $250,000 of Energy Transfer Stock according to a recent report

    June 6, 2023By James0

    Rhode Island is One Step Closer to Legalizing Psilocybin for Therapeutic Use and Cultivation

    June 6, 2023By James0

    Leave A Reply Cancel Reply

    Our Picks

    Your Investment Went Up 10,000%, Now What Should You Do, Sell or Let it Ride? – NVIDIA (NASDAQ:NVDA)

    June 6, 2023

    HCA Healthcare (HCA) Favors Higher In Bullish Sequence & Remain Supported

    June 6, 2023

    Datalink Networks Taps Former Microsoft Senior Solutions Architect Aman Sahota as Director of Engineering

    June 6, 2023

    Topeka, Kansas, Offers $15K Relocation Incentive for New Residents

    June 6, 2023
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss

    Paratek Pharmaceuticals to be Acquired by Gurnet Point and Novo Holdings for $462M – PRTK Stock

    Stock Market June 6, 2023

    Biopharmaceutical company Paratek Pharmaceuticals, Inc. (PRTK) has agreed to be acquired by Gurnet Point Capital and Novo Holdings A/S, both investment firms, in a deal worth approximately $462 million, which includes debt and assuming full payment of a Contingent Value Right (CVR). Paratek will be acquired for $2.15 per share…

    Limoneira (LMNR) Q2 2023 Earnings Call Transcript

    June 6, 2023

    7,376 ETH Worth $13M Has Been Burned

    June 6, 2023

    Hoth Therapeutics Stock Surges on Promising Preclinical Results for Alzheimer’s Disease Treatment

    June 6, 2023
    FEATURED INSIGHTS​

    Unleashing the Potential of Cell Therapy with Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP)

    June 6, 2023

    Virtus Junxit Equity Report: Loop Media, Inc. (AMEX: LPTV)

    May 31, 2023

    Virtus Junxit Equity Research: Hillstream BioPharma, Inc. (NASDAQ: HILS)

    May 18, 2023

    NeuroOne Medical NMTC Extreme Potential in Medical Tech

    May 14, 2023

    Subscribe to stay informed!

    Discover hidden stock market gems and stay up to date with our weekly email newsletter and individual stock ideas

    Telegram RSS
    • Home
    • Privacy Policy
    • Disclaimer
    • Virtus Report
    • Get Access
    © 2023 Virtus Junxit LLC

    Type above and press Enter to search. Press Esc to cancel.